the question I don't really have an answer for is what sales will look like following approval. will ramp up take longer than expected etc. after a few quarters I see the sales being what drives the company value (of course in combo with clinical program for other products). expecting a pop on fda announcement (assuming successful) but am in for the long term so won't be trying to trade it..
Radiopharm - anyone know how this compares to TLX?, page-34
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add TLX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$17.99 |
Change
0.190(1.07%) |
Mkt cap ! $6.020B | |||
| Open | High | Low | Value | Volume |
| $17.98 | $18.01 | $17.73 | $10.89M | 609.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1237 | $17.98 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $17.99 | 1159 | 1 |
View Market Depth
| Last trade - 16.10pm 12/08/2024 (20 minute delay) ? |
| TLX (ASX) Chart |